© 2023 90.7 WMFE. All Rights Reserved.
Public Media News for Central Florida
Play Live Radio
Next Up:
0:00 0:00
Available On Air Stations

Researchers in DeLand are looking for participants to enroll in an RSV vaccine trial

Photo: Pixabay
Photo: Pixabay

Researchers in Orlando and DeLand are looking for people to enroll in clinical trials for a combination RSV, COVID and flu vaccine. 

RSV usually causes mild flu-like symptoms in most people, but in children under 1 and adults 65 and older, it can be deadly. 

Cases and hospitalizations are on the rise here in Central Florida, which is why Dr. Bruce Rankin, who runs the trials at Accel Research Sites, says participants can save lives. 

“Now, with some of the newer technology we're using in development of vaccines, we have a better chance of being able to get a valuable RSV vaccine available. And so it's going to help limit the, hopefully the hospitalizations in the future for both children and people over 60. Because there's still about 14,000 or so deaths a year for adults over 60 because of RSV.”

Rankin says anyone 50 and up can enroll. 

“So what it involves, for the current trial that is enrolling is having been vaccinated for the original series of COVID with and without a booster, 50 years of age and older, and have not had a recent flu shot. So the group that we're doing now is a combination between flu, COVID vaccine and RSV.”

Rankin expects a single shot for RSV to be available by the new year, and a combination RSV, COVID and flu shot to be ready by next fall. 

To find out how you can enroll in a clinical trial, visit accelresearchsites.com.

Danielle Prieur is a general assignment reporter and fill-in host at WMFE.
90.7 WMFE relies on donors like you. Your support allows us to provide independent, trustworthy journalism and fact-based content. Show your support today by contributing on a monthly basis or making a single online donation.